Effects of smoking status, history and intensity on heart rate variability in the general population: The CHRIS study.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
06
08
2018
accepted:
26
03
2019
entrez:
10
4
2019
pubmed:
10
4
2019
medline:
28
12
2019
Statut:
epublish
Résumé
Heart rate variability (HRV) reflects the autonomous nervous system modulation on heart rate and is associated with several pathologies, including cardiac mortality. While mechanistic studies show that smoking is associated with lower HRV, population-based studies present conflicting results. We assessed the mutual effects of active smoking status, cumulative smoking history, and current smoking intensity, on HRV among 4751 adults from the Cooperative Health Research In South Tyrol (CHRIS) study. The HRV metrics standard deviation of normal-to-normal (NN) inter-beat intervals (SDNN), square root of the mean squared differences of consecutive NN intervals (RMSSD), total power (TP), low (LF) and high frequency (HF) power, and their ratio (LF/HF), were derived from 20-minute electrocardiograms. Smoking status, pack-years (PY), and tobacco grams/day from standardized questionnaires were the main exposures. We fitted linear mixed models to account for relatedness, non-linearity, and moderating effects, and including fractional polynomials. Past smokers had higher HRV levels than never smokers, independently of PY. The association of HRV with current smoking became apparent when accounting for the interaction between smoking status and PY. In current smokers, but not in past smokers, we observed HRV reductions between 2.0% (SDNN) and 4.9% (TP) every 5 PY increase. Furthermore, current smokers were characterized by dose-response reductions of 9.8% (SDNN), 8.9% (RMSSD), 20.1% (TP), 17.7% (LF), and 19.1% (HF), respectively, every 10 grams/day of smoked tobacco, independently of common cardiometabolic conditions and HRV-modifying drugs. The LF/HF ratio was not associated with smoking status, history, or intensity. Smoking cessation was associated with higher HRV levels. In current smokers, heavier smoking intensity appears gradually detrimental on HRV, corroborating previous evidence. By affecting both the sympathetic and parasympathetic nervous system indexes, but not the LF/HF balance, smoking intensity seems to exert a systemic dysautonomic effect.
Sections du résumé
BACKGROUND
Heart rate variability (HRV) reflects the autonomous nervous system modulation on heart rate and is associated with several pathologies, including cardiac mortality. While mechanistic studies show that smoking is associated with lower HRV, population-based studies present conflicting results.
METHODS
We assessed the mutual effects of active smoking status, cumulative smoking history, and current smoking intensity, on HRV among 4751 adults from the Cooperative Health Research In South Tyrol (CHRIS) study. The HRV metrics standard deviation of normal-to-normal (NN) inter-beat intervals (SDNN), square root of the mean squared differences of consecutive NN intervals (RMSSD), total power (TP), low (LF) and high frequency (HF) power, and their ratio (LF/HF), were derived from 20-minute electrocardiograms. Smoking status, pack-years (PY), and tobacco grams/day from standardized questionnaires were the main exposures. We fitted linear mixed models to account for relatedness, non-linearity, and moderating effects, and including fractional polynomials.
RESULTS
Past smokers had higher HRV levels than never smokers, independently of PY. The association of HRV with current smoking became apparent when accounting for the interaction between smoking status and PY. In current smokers, but not in past smokers, we observed HRV reductions between 2.0% (SDNN) and 4.9% (TP) every 5 PY increase. Furthermore, current smokers were characterized by dose-response reductions of 9.8% (SDNN), 8.9% (RMSSD), 20.1% (TP), 17.7% (LF), and 19.1% (HF), respectively, every 10 grams/day of smoked tobacco, independently of common cardiometabolic conditions and HRV-modifying drugs. The LF/HF ratio was not associated with smoking status, history, or intensity.
CONCLUSIONS
Smoking cessation was associated with higher HRV levels. In current smokers, heavier smoking intensity appears gradually detrimental on HRV, corroborating previous evidence. By affecting both the sympathetic and parasympathetic nervous system indexes, but not the LF/HF balance, smoking intensity seems to exert a systemic dysautonomic effect.
Identifiants
pubmed: 30964923
doi: 10.1371/journal.pone.0215053
pii: PONE-D-18-23132
pmc: PMC6456196
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0215053Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Arch Gerontol Geriatr. 2016 Mar-Apr;63:1-8
pubmed: 26791165
Lancet. 2005 May 7-13;365(9471):1629-35; discussion 1600-1
pubmed: 15885295
Acta Paediatr. 2010 Apr;99(4):604-11
pubmed: 20121706
Conf Proc IEEE Eng Med Biol Soc. 2011;2011:681-2
pubmed: 22254401
J Am Coll Cardiol. 1996 Nov 15;28(6):1539-46
pubmed: 8917269
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
Neurosci Lett. 2009 Oct 2;462(1):20-3
pubmed: 19573576
Ann Noninvasive Electrocardiol. 2005 Jul;10(3):324-9
pubmed: 16029383
Int J Cardiol. 2013 Feb 20;163(2):109-15
pubmed: 22100604
Environ Toxicol Pharmacol. 2014 Jan;37(1):404-13
pubmed: 24444697
Int J Womens Health. 2013 Oct 17;5:667-79
pubmed: 24204174
Am J Cardiol. 1993 Oct 15;72(12):897-903
pubmed: 8213546
J Am Coll Cardiol. 2014 Oct 21;64(16):1740-50
pubmed: 25323263
Stat Med. 2010 May 20;29(11):1219-27
pubmed: 20191601
Am J Cardiol. 2010 Apr 15;105(8):1181-5
pubmed: 20381674
J Sleep Res. 2007 Jun;16(2):148-55
pubmed: 17542944
Circulation. 1996 Dec 1;94(11):2850-5
pubmed: 8941112
Einstein (Sao Paulo). 2015 Jan-Mar;13(1):27-33
pubmed: 25993065
J Clin Epidemiol. 1997 Aug;50(8):947-52
pubmed: 9291880
Circulation. 1993 Sep;88(3):927-34
pubmed: 8353919
Gesundheitswesen. 2005 Aug;67 Suppl 1:S19-25
pubmed: 16032513
J Transl Med. 2015 Nov 05;13:348
pubmed: 26541195
Clin Nutr. 2019 Feb;38(1):110-126
pubmed: 29395374
J Korean Med Sci. 2011 Oct;26(10):1293-8
pubmed: 22022180
Oncol Rep. 2013 Nov;30(5):2435-41
pubmed: 24026706
Environ Res. 2015 Nov;143(Pt A):39-48
pubmed: 26432956
Ann Noninvasive Electrocardiol. 2009 Oct;14(4):327-32
pubmed: 19804508
J Diabetes Res. 2016;2016:8483537
pubmed: 27191000
Int J Behav Med. 2014 Apr;21(2):302-9
pubmed: 23397454
Circulation. 1996 Mar 1;93(5):1043-65
pubmed: 8598068
Conf Proc IEEE Eng Med Biol Soc. 2004;2004:3254-7
pubmed: 17270974
Eur J Epidemiol. 2009;24(3):123-42
pubmed: 19199053
J Am Coll Cardiol. 1992 Jul;20(1):248-54
pubmed: 1351488
Hum Genet. 2017 Jun;136(6):743-757
pubmed: 28374192
Eur J Prev Cardiol. 2016 Jul;23(10):1037-44
pubmed: 26701874
Scand J Work Environ Health. 2005 Oct;31(5):360-6
pubmed: 16273962
Europace. 2006 Jul;8(7):521-9
pubmed: 16798766
Life Sci. 2005 Oct 7;77(21):2723-34
pubmed: 15978638
Diabetes Metab Res Rev. 2011 Oct;27(7):654-64
pubmed: 21695761
Ann Neurol. 2015 May;77(5):877-83
pubmed: 25707861
Ann Noninvasive Electrocardiol. 2008 Apr;13(2):137-44
pubmed: 18426439